Advanced Analytical Strategies for NextGen Antibodies

ADC represents a powerful therapeutic modality for solid tumors and hematological malignancies, but challenges such as in vitro-in vivo translation, PK interpretation, candidate differentiation, safety risks, and narrow therapeutic window can complicate the drug discovery process. Discover our consolidated scientific resources featuring stage-based strategies, case studies, and actionable insights to help address these challenges and support informed ADC lead optimization and candidate progression.